Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Leukemia, B-Cell × ofatumumab × Clear all

Phase

Phase 2 7 Phase 3 3 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1

Interventions

ofatumumab 1 obinutuzumab 1 ibrutinib 1 acalabrutinib 1 Rituximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00802737 2014-05-14

Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL)

GlaxoSmithKline

Phase 4 Completed

29 enrolled 18 charts

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡